Vivos Therapeutics, Inc. (VVOS)
0.2765
-0.02
(-6.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.2735
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Profit Margin (Quarterly) : -107.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -107.2% |
| March 31, 2026 | -150.8% |
| December 31, 2025 | -181.9% |
| September 30, 2025 | -79.61% |
| June 30, 2025 | -131.2% |
| March 31, 2025 | -128.1% |
| December 31, 2024 | -76.45% |
| September 30, 2024 | -67.77% |
| June 30, 2024 | -47.61% |
| March 31, 2024 | -110.1% |
| December 31, 2023 | -131.1% |
| September 30, 2023 | -63.40% |
| June 30, 2023 | -162.8% |
| March 31, 2023 | -44.15% |
| Date | Value |
|---|---|
| December 31, 2022 | -154.2% |
| September 30, 2022 | -128.0% |
| June 30, 2022 | -167.1% |
| March 31, 2022 | -146.3% |
| December 31, 2021 | -168.2% |
| September 30, 2021 | -120.0% |
| June 30, 2021 | -89.90% |
| March 31, 2021 | -98.59% |
| December 31, 2020 | -297.8% |
| September 30, 2020 | -55.09% |
| March 31, 2020 | -80.73% |
| December 31, 2019 | -85.97% |
| September 30, 2019 | -93.24% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Hinge Health, Inc. | 20.25% |
| Exlites Holdings International, Inc. | -38.74% |
| Xcelerate, Inc. | -- |
| Haemonetics Corp. | 9.73% |
| Pro-Dex, Inc. | 19.74% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.07K% |
| Return on Assets | -101.7% |
| Return on Invested Capital | -204.5% |
| Gross Profit Margin (Quarterly) | 47.41% |
| Operating Margin (Quarterly) | -93.63% |
| Return on Net Operating Assets | -114.6% |